OUP Management Co., LLC 13F Holdings · last filed Q3 2023
OUP Management Co., LLC reported 12 securities worth $44.47M in its SEC 13F filing for Q3 2023 (period ended 2023-09-30). Top holdings: CNTA (42.74%), JBIO (18.43%), CYT (15.71%). Among its top 25 positions this quarter: 1 new, 1 exited.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | CNTA | Centessa Pharmaceuticals plc | $19.0M | 42.74% | 2.9M | Hold |
| 2 | JBIO | Aerovate Therapeutics Inc. | $8.2M | 18.43% | 603,762 | Hold |
| 3 | CYT | Cyteir Therapeutics, Inc. | $7.0M | 15.71% | 2.5M | Hold |
| 4 | PMVP | PMV Pharmaceuticals, Inc. | $6.1M | 13.66% | 989,232 | Hold |
| 5 | LENZ | Graphite Bio | $1.0M | 2.27% | 406,308 | Hold |
| 6 | SELB | Selecta Biosciences, Inc. | $914,296 | 2.06% | 862,543 | Hold |
| 7 | VOR | Vor Biopharma Inc. | $794,394 | 1.79% | 374,714 | Hold |
| 8 | EFTR | eFFECTOR Therapeutics, Inc. | $615,316 | 1.38% | 1.0M | Hold |
| 9 | DTIL | Precision BioSciences, Inc. | $383,592 | 0.86% | 1.1M | Hold |
| 10 | SPRO | Spero Therapeutics, Inc. | $301,375 | 0.68% | 249,070 | Hold |
| 11 | IKNA | Ikena Oncology, Inc. | $116,187 | 0.26% | 26,833 | New |
| 12 | QTTB | Homology Medicines, Inc. | $74,880 | 0.17% | 64,000 | Hold |
| 13 | DICE | DICE Therapeutics Inc. | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2023-09-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR